Se-cure Pharmaceuticals Competitors and Similar CompaniesClear all

Se-cure Pharmaceuticals's competitors and similar companies include Sosei Heptares, Kamada Pharmaceuticals, Heron Therapeutics and JCR Pharmaceuticals.

	Se-cure Pharmaceuticals Se-cure Pharmaceuticals is a research-driven pharmaceutical company that develops a platform for the development and scaling of therapies of botanical origin.	Sosei Heptares Sosei Heptares is a biopharmaceutical company that specializes in drug development.	Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.	Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.	JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
Founding Date	Founding Date 1997	Founding Date 1990	Founding Date 1990	Founding Date 1983	Founding Date 1975
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations HQ	Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB	Locations Rehovot, IL HQ Beit Kama, IL	Locations San Diego, US HQ	Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP
Employees	Employees 195% decrease	Employees 387	Employees 420	Employees 20333% decrease	Employees 934
Valuation ($)	Valuation ($) N/A	Valuation ($) 697 m	Valuation ($) 317 m	Valuation ($) 268.5 m	Valuation ($) 533.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥29.6b (FY, 2025)	Revenue (est.) $180.5m (FY, 2025)	Revenue (est.) $154.9m (FY, 2025)	Revenue (est.) ¥33.1b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥7.3b (FY, 2025)	Cost of goods $72.1m (FY, 2025)	Cost of goods $41.3m (FY, 2025)	Cost of goods ¥8b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥24b (FY, 2025)	Gross profit $108.4m (FY, 2025)	Gross profit $113.6m (FY, 2025)	Gross profit ¥25.1b (FY, 2025)
Net income	Net income N/A	Net income (¥12.5b) (FY, 2025)	Net income $20.2m (FY, 2025)	Net income ($20.2m) (FY, 2025)	Net income (¥4.7b) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 65m	Total funding raised $ 90m	Total funding raised N/A	Total funding raised N/A